poisar

Stock

Sionna Therapeutics, Inc. SION

$6.06-1.86%

Overview

SION market data

Price History

SION price chart · 1M
O
6.13
H
6.16
L
5.98
C
6.06
Vol
26,387.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$6.13
Previous Close
$6.18
Day High
$6.16
Day Low
$5.98
52 Week High
$54.71
52 Week Low
$4.02
7 Day Return
+9.88%
30 Day Return
-87.01%
90 Day Return
-85.86%
1 Year Return
-83.76%
Daily Notional Volume
$159.9K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.88
Diluted earnings per share over the trailing twelve months.
Beta
1.38
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.01 – $54.97
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $295.7M · P/B 5.98.

Company News

10 captured
Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmGlobenewswire Inc · Aug 26, 2026, 9:15 PM
Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzGlobenewswire Inc · Aug 25, 2026, 7:15 PM
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still AheadThe Motley Fool · Aug 20, 2026, 8:15 PM
Guggenheim Downgrades Sionna Therapeutics to NeutralBenzinga · Aug 11, 2026, 2:17 PM
Wedbush Downgrades Sionna Therapeutics to Neutral, Lowers Price Target to $5Benzinga · Aug 11, 2026, 1:43 PM
Sionna Therapeutics Discontinues Cystic Fibrosis Drug Following Unfavorable Data Data, Stock TanksBenzinga · Aug 10, 2026, 6:02 PM
Crude Oil Surges 3%; Sionna Therapeutics Shares PlungeBenzinga · Aug 10, 2026, 4:19 PM
US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 ResultsBenzinga · Aug 10, 2026, 1:40 PM
12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · Aug 10, 2026, 12:06 PM
Sionna Therapeutics shares are trading lower after the company reported topline data from the PreciSION CF Phase 2a proof-of-concept trial of SION-719 did not achieve key activity endpoint.Benzinga · Aug 10, 2026, 11:37 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock